• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

利用反义寡核苷酸改善对微小RNA的靶向作用。

Improved targeting of miRNA with antisense oligonucleotides.

作者信息

Davis Scott, Lollo Bridget, Freier Susan, Esau Christine

机构信息

Isis Pharmaceuticals 1896 Rutherford Road, Carlsbad, CA 92008, USA.

出版信息

Nucleic Acids Res. 2006 May 11;34(8):2294-304. doi: 10.1093/nar/gkl183. Print 2006.

DOI:10.1093/nar/gkl183
PMID:16690972
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1459537/
Abstract

MicroRNAs (miRNAs) are a class of 20-24 nt noncoding RNAs that regulate target mRNAs post-transcriptionally by binding with imperfect complementarity in the 3'-untranslated region (3'-UTR) and inhibiting translation or RNA stability. Current understanding of miRNA biology is limited, and antisense oligonucleotide (ASO) inhibition is a powerful technique for miRNA functionalization in vitro and in vivo, and for therapeutic targeting of miRNAs. Identification of optimal ASO chemistries for targeting miRNAs is therefore of great interest. We evaluated a number of 2'-sugar and backbone ASO modifications for their ability to inhibit miR-21 activity on a luciferase reporter mRNA. ASO modifications that improved target affinity improved miRNA ASO activity, yet the positioning of high-affinity modifications also had dramatically different effects on miRNA activity, suggesting that more than affinity determined the effectiveness of the miRNA ASOs. We present data in which the activity of a modified miRNA ASO was inversely correlated to its tolerability as an siRNA passenger strand, suggesting that a similar mechanism could be involved in the dissociation of miRNA ASOs and siRNA passenger strands. These studies begin to define the factors important for designing improved miRNA ASOs, enabling more effective miRNA functionalization and therapeutic targeting.

摘要

微小RNA(miRNA)是一类20 - 24个核苷酸的非编码RNA,它们通过在3'非翻译区(3'-UTR)与靶mRNA不完全互补结合,在转录后水平调节靶mRNA,抑制其翻译或影响RNA稳定性。目前对miRNA生物学的了解有限,反义寡核苷酸(ASO)抑制是一种在体外和体内实现miRNA功能化以及对miRNA进行治疗性靶向的强大技术。因此,确定用于靶向miRNA的最佳ASO化学结构备受关注。我们评估了多种2'-糖基和骨架ASO修饰对荧光素酶报告基因mRNA上miR-21活性的抑制能力。改善靶标亲和力的ASO修饰提高了miRNA ASO活性,但高亲和力修饰的位置对miRNA活性也有显著不同的影响,这表明决定miRNA ASO有效性的因素不止亲和力。我们提供的数据表明,修饰后的miRNA ASO活性与其作为小干扰RNA(siRNA)过客链的耐受性呈负相关,这表明miRNA ASO和siRNA过客链的解离可能涉及类似机制。这些研究开始确定设计改良型miRNA ASO的重要因素,从而实现更有效的miRNA功能化和治疗性靶向。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/05ff/1459537/ee86f9d63808/gkl183f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/05ff/1459537/7cb70da7553b/gkl183f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/05ff/1459537/83f5ec3f7266/gkl183f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/05ff/1459537/34afc2607caa/gkl183f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/05ff/1459537/928c18966ba8/gkl183f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/05ff/1459537/ae8241d9ebe5/gkl183f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/05ff/1459537/ee86f9d63808/gkl183f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/05ff/1459537/7cb70da7553b/gkl183f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/05ff/1459537/83f5ec3f7266/gkl183f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/05ff/1459537/34afc2607caa/gkl183f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/05ff/1459537/928c18966ba8/gkl183f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/05ff/1459537/ae8241d9ebe5/gkl183f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/05ff/1459537/ee86f9d63808/gkl183f6.jpg

相似文献

1
Improved targeting of miRNA with antisense oligonucleotides.利用反义寡核苷酸改善对微小RNA的靶向作用。
Nucleic Acids Res. 2006 May 11;34(8):2294-304. doi: 10.1093/nar/gkl183. Print 2006.
2
A highly effective and long-lasting inhibition of miRNAs with PNA-based antisense oligonucleotides.基于肽核酸的反义寡核苷酸对 miRNAs 具有高效且持久的抑制作用。
Mol Cells. 2009 Oct 31;28(4):341-5. doi: 10.1007/s10059-009-0134-8. Epub 2009 Sep 30.
3
Potent inhibition of microRNA in vivo without degradation.在体内对微小RNA进行有效抑制而不发生降解。
Nucleic Acids Res. 2009 Jan;37(1):70-7. doi: 10.1093/nar/gkn904. Epub 2008 Nov 16.
4
An overview of sugar-modified oligonucleotides for antisense therapeutics.用于反义治疗的糖修饰寡核苷酸概述。
Chem Biodivers. 2011 Sep;8(9):1616-41. doi: 10.1002/cbdv.201100081.
5
Non-nucleotide Modification of Anti-miRNA Oligonucleotides.抗微小RNA寡核苷酸的非核苷酸修饰
Methods Mol Biol. 2017;1517:51-69. doi: 10.1007/978-1-4939-6563-2_3.
6
Disarmed anthrax toxin delivers antisense oligonucleotides and siRNA with high efficiency and low toxicity.去毒炭疽毒素高效低毒传递反义寡核苷酸和 siRNA。
J Control Release. 2015 Dec 28;220(Pt A):316-328. doi: 10.1016/j.jconrel.2015.10.054. Epub 2015 Nov 9.
7
Translation can affect the antisense activity of RNase H1-dependent oligonucleotides targeting mRNAs.翻译会影响针对 mRNA 的 RNase H1 依赖性寡核苷酸的反义活性。
Nucleic Acids Res. 2018 Jan 9;46(1):293-313. doi: 10.1093/nar/gkx1174.
8
Bifunctional small molecule-oligonucleotide hybrid as microRNA inhibitor.双功能小分子-寡核苷酸杂交体作为 microRNA 抑制剂。
Bioorg Med Chem. 2020 Apr 1;28(7):115394. doi: 10.1016/j.bmc.2020.115394. Epub 2020 Feb 18.
9
Hsp90 protein interacts with phosphorothioate oligonucleotides containing hydrophobic 2'-modifications and enhances antisense activity.热休克蛋白90(Hsp90)与含有疏水性2'-修饰的硫代磷酸酯寡核苷酸相互作用,并增强反义活性。
Nucleic Acids Res. 2016 May 5;44(8):3892-907. doi: 10.1093/nar/gkw144. Epub 2016 Mar 3.
10
Strategies to antagonize miRNA functions in vitro and in vivo.在体外和体内拮抗微小RNA(miRNA)功能的策略。
Nanomedicine (Lond). 2014 Nov;9(16):2545-55. doi: 10.2217/nnm.14.162.

引用本文的文献

1
Chemical Modifications in Nucleic Acid Therapeutics.核酸疗法中的化学修饰
Methods Mol Biol. 2025;2965:57-126. doi: 10.1007/978-1-0716-4742-4_3.
2
CircRNA-based AntimiR therapy: A novel approach to hypertension treatment.基于环状RNA的抗miR治疗:高血压治疗的新方法。
Noncoding RNA Res. 2025 May 5;13:94-108. doi: 10.1016/j.ncrna.2025.05.001. eCollection 2025 Aug.
3
Circular Nucleic Acids Act as an Oncogenic MicroRNA Sponge to Inhibit Hepatocellular Carcinoma Progression.环状核酸作为一种致癌性微小RNA海绵,抑制肝细胞癌进展。

本文引用的文献

1
Use of a chemically modified antisense oligonucleotide library to identify and validate Eg5 (kinesin-like 1) as a target for antineoplastic drug development.使用化学修饰的反义寡核苷酸文库来鉴定和验证驱动蛋白样蛋白1(Eg5)作为抗肿瘤药物开发的靶点。
Cancer Res. 2006 Feb 15;66(4):2059-66. doi: 10.1158/0008-5472.CAN-05-1531.
2
A microRNA expression signature of human solid tumors defines cancer gene targets.人类实体瘤的微小RNA表达特征可确定癌症基因靶点。
Proc Natl Acad Sci U S A. 2006 Feb 14;103(7):2257-61. doi: 10.1073/pnas.0510565103. Epub 2006 Feb 3.
3
miR-122 regulation of lipid metabolism revealed by in vivo antisense targeting.
Biomedicines. 2025 May 11;13(5):1171. doi: 10.3390/biomedicines13051171.
4
Exosome-based nanomedicines for digestive system tumors therapy.用于消化系统肿瘤治疗的基于外泌体的纳米药物。
Nanomedicine (Lond). 2025 May;20(10):1167-1180. doi: 10.1080/17435889.2025.2493037. Epub 2025 Apr 18.
5
MiRNAs as major players in brain health and disease: current knowledge and future perspectives.微小RNA作为大脑健康与疾病的主要参与者:当前认知与未来展望
Cell Death Discov. 2025 Jan 13;11(1):7. doi: 10.1038/s41420-024-02283-x.
6
Diagnostic and Prognostic Role of Circulating microRNAs in Patients with Coronary Artery Disease-Impact on Left Ventricle and Arterial Function.循环微RNA在冠状动脉疾病患者中的诊断和预后作用——对左心室和动脉功能的影响
Curr Issues Mol Biol. 2024 Aug 3;46(8):8499-8511. doi: 10.3390/cimb46080500.
7
Oligonucleotide therapies for nonalcoholic steatohepatitis.用于非酒精性脂肪性肝炎的寡核苷酸疗法。
Mol Ther Nucleic Acids. 2024 Mar 30;35(2):102184. doi: 10.1016/j.omtn.2024.102184. eCollection 2024 Jun 11.
8
Decoding contextual crosstalk: revealing distinct interactions between non-coding RNAs and unfolded protein response in breast cancer.解码上下文串扰:揭示乳腺癌中非编码RNA与未折叠蛋白反应之间的独特相互作用
Cancer Cell Int. 2024 Mar 11;24(1):104. doi: 10.1186/s12935-024-03296-3.
9
MiR-128-3p - a gray eminence of the human central nervous system.微小RNA-128-3p——人类中枢神经系统的一个无名小卒。
Mol Ther Nucleic Acids. 2024 Feb 6;35(1):102141. doi: 10.1016/j.omtn.2024.102141. eCollection 2024 Mar 12.
10
microRNA-1 regulates sea urchin skeletogenesis by directly targeting skeletogenic genes and modulating components of signaling pathways.microRNA-1 通过直接靶向骨骼生成基因和调节信号通路的组成部分来调节海胆骨骼生成。
Dev Biol. 2024 Apr;508:123-137. doi: 10.1016/j.ydbio.2024.01.010. Epub 2024 Jan 28.
体内反义靶向揭示miR-122对脂质代谢的调控
Cell Metab. 2006 Feb;3(2):87-98. doi: 10.1016/j.cmet.2006.01.005.
4
The role of PACT in the RNA silencing pathway.PACT在RNA沉默途径中的作用。
EMBO J. 2006 Feb 8;25(3):522-32. doi: 10.1038/sj.emboj.7600942. Epub 2006 Jan 19.
5
A brain-specific microRNA regulates dendritic spine development.一种大脑特异性微小RNA调节树突棘的发育。
Nature. 2006 Jan 19;439(7074):283-9. doi: 10.1038/nature04367.
6
GTI-2501, an antisense agent targeting R1, the large subunit of human ribonucleotide reductase, shows potent anti-tumor activity against a variety of tumors.GTI-2501是一种靶向人核糖核苷酸还原酶大亚基R1的反义药物,对多种肿瘤显示出强大的抗肿瘤活性。
Int J Oncol. 2006 Feb;28(2):469-78.
7
miRBase: microRNA sequences, targets and gene nomenclature.miRBase:微小RNA序列、靶标及基因命名法。
Nucleic Acids Res. 2006 Jan 1;34(Database issue):D140-4. doi: 10.1093/nar/gkj112.
8
Argonaute--a database for gene regulation by mammalian microRNAs.AGO2数据库——哺乳动物微小RNA介导的基因调控数据库
Nucleic Acids Res. 2006 Jan 1;34(Database issue):D115-8. doi: 10.1093/nar/gkj093.
9
MicroRNAs as oncogenes.作为致癌基因的微小RNA
Curr Opin Genet Dev. 2006 Feb;16(1):4-9. doi: 10.1016/j.gde.2005.12.005. Epub 2005 Dec 19.
10
A human, ATP-independent, RISC assembly machine fueled by pre-miRNA.一种由前体微小RNA驱动的、不依赖ATP的人类RNA诱导沉默复合体组装机器。
Genes Dev. 2005 Dec 15;19(24):2979-90. doi: 10.1101/gad.1384005.